Form 4: Tenet Healthcare Director Cecil Haney Reports Routine Stock Transactions and New RSU Grant

Tenet Healthcare Corp. Director Cecil D. Haney reported the exercise of restricted stock units, a subsequent sale of common stock, and the grant of new restricted stock units, as detailed in a recent SEC Form 4 filing.

Summary

• Director Cecil D. Haney, a Director at Tenet Healthcare Corp. (THC), filed a Form 4 detailing recent stock transactions.
• On May 23, 2025, Mr. Haney acquired 1,551 shares of THC common stock through the exercise of restricted stock units (RSUs).
• Concurrently, on May 23, 2025, he disposed of 573 shares of common stock at a price of $161.33 per share.
• On May 22, 2025, Mr. Haney was granted 1,333 new restricted stock units under the Company's Stock Incentive Plan.
• Following these transactions, Mr. Haney directly beneficially owns 13,013 shares of common stock and 1,333 restricted stock units.
• The settlement of the exercised RSUs involved 37% in cash and 63% in shares of THC common stock.

Sentiment

Score: 5

Explanation: The document reports routine insider transactions, including both an RSU exercise and a small sale, alongside a new RSU grant. This is a neutral event, typical for executive compensation and personal financial management, and does not indicate significant positive or negative sentiment about the company's performance or outlook.

Positives

• Grant of 1,333 new Restricted Stock Units to Director Cecil D. Haney, indicating continued incentive alignment with company performance.
• The acquisition of 1,551 shares through RSU exercise demonstrates the conversion of equity incentives into direct stock ownership.

Negatives

• Sale of 573 shares of common stock by a director, which could be interpreted as a reduction in direct ownership, although it's a relatively small portion of total holdings.

Future Outlook

The newly granted 1,333 Restricted Stock Units are scheduled to vest on May 22, 2026, aligning the director's future compensation with the company's performance over the next year.

Management Comments

• Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock.
• The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock.
• These restricted stock units vest on the first anniversary of the date of grant.
• The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares.

Industry Context

This Form 4 filing details routine insider equity transactions for a director at a major healthcare services provider. Such transactions are common for executives and directors as part of their compensation and personal financial management, and do not inherently reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Provides transparency regarding director stock ownership and transactions, which is standard for corporate governance. The sale of a small number of shares might be viewed neutrally or slightly negatively, while the RSU grant aligns director interests with long-term shareholder value.

Next Steps

• The newly granted 1,333 Restricted Stock Units are scheduled to vest on May 22, 2026.

Key Dates

Keywords

Tenet Healthcare, THC, SEC Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU, Director, Equity Compensation, Healthcare